FAFahad Albadr

Fahad Albadr

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fahad Albadr has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Stroke incidence and phenotype in Saudi patients with sickle cell disease: A longitudinal cohort study

    by Mohammed Al‐Agha, Fahad Albadr, Aamer Aleem, Farjah H. Algahtani, Ali Al‐Shehri, Fahad Bashiri, Abdulrahman Alsultan

    Summary: Stroke is a major cause of morbidity in sickle cell disease (SCD); however, contemporary longitudinal data from Saudi cohorts remain limited. We examined stroke incidence, phenotype and laboratory correlates in 195 patients with homozygous sickle cell anaemia (HbSS) or sickle β⁰‐thalassaemia (HbS/β⁰), predominantly from southwestern regions (median age at enrolment, 16.5 years; 53% male; median baseline haemoglobin, 8.9 g/dL; fetal haemoglobin [HbF], 10.5%), followed for a median of 13.5 years (2009–2025; 2173 patient‐years). Hydroxyurea (hydroxycarbamide) use increased from 44% at enrolment to 85% at follow‐up. Fourteen strokes (13 ischaemic, 1 haemorrhagic) occurred at a median age of 28 years, an overall incidence of 0.64 per 100 patient‐years (0.39 in 30 years), with no overt stroke before age 10. By age 30, cumulative incidence of overt ischaemic stroke and silent cerebral infarcts (SCIs) reached 5.0% and 18.6% respectively. In age‐ and sex‐adjusted models, higher baseline lactate dehydrogenase (LDH) was associated with ischaemic stroke (incidence rate ratio [IRR], 1.46 per 100 U/L; 95% confidence interval [CI], 1.11–1.91; p = 0.007); HbF showed a protective trend (IRR 0.55 per 5% increase; 95% CI, 0.29–1.06; p = 0.07). This age‐related stroke pattern without a childhood peak may reflect higher baseline HbF, expanded hydroxyurea use, and supportive care improvements, although population‐specific modifiers cannot be excluded.

  • Spinal epidural abscess mimicking chloroma

    by Fahad Albadr, Khalid Aldossari, Naif Aldossari, Meshal Alghamdi, Nawaf Alluwaymi, Abdulaziz Alohali

    Background: Spinal epidural abscess (SEA) is a rare and generally challenging condition. It represents a challenge in terms of diagnosis and treatment due to the low incidence, vague presentation, and rapid neurologic deterioration. Case Presentation: A 40-year-old gentleman who was previously healthy was presented with a 2-week history of decreased vision associated with fever and cough one week before the eye symptoms. The patient was admitted as a case of acute promyelocytic leukemia. And was started on chemotherapy, which was complicated by septicemia and was shifted to the intensive care unit. Three weeks after admission he started to have severe non-radicular neck pain. He also had bilateral lower limb pain spasm-like in nature. Patient denies any history of trauma, weakness, numbness, saddle anesthesia or loss of sphincter control. Labs showed leukopenia, anemia and thrombocytopenia. Bone marrow result showed hypercellularity with active trilineage hematopoiesis and no immunomorphological evidence of abnormal promyelocytes or maturation arrest. He underwent C3-C4 laminectomy and evacuation of epidural pus collection. Intra-operative course was free of complication. Upon post-operative assessment he was hemodynamically stable, his neck pain was better with morphine doses and he was able to mobilize it. Conclusion: Spinal epidural abscess can mimic chloroma clinically and radiologically, however, diffusion with the images and enhancement is essential for proper assessment since a proper medical and surgical intervention is needed.

  • Open Access

    Uremic Leontiasis Ossea in a Pediatric Patient

    by Hisham K. Algossy, Fahad Albadr, Abdullah Y. Aloraini, Mohammed K. Alsayyar, Abdullah H. AlHindi

    Uremic leontiasis ossea (ULO) is a rare disease characterized by extensive thickening of the cranium, resulting in a characteristic, lion-like facial appearance. It is considered the most severe osseous complication of renal dystrophy. Although rare, ULO can occur even in young patients, which can be catastrophic, as it can not only lead to life-threatening conditions but also multiple complications that cause severe determent to the quality of life.

  • Open Access

    Ipsilateral Hemispheric Brain Atrophy in an Asymptomatic Child With Linear Morphea: A Case Report

    by Fahad Albadr, Hebah A Alnasser, Reem M. Alshathri

    Scleroderma is a family of systemic and local diseases that tighten and harden the skin and other connective tissues. Local scleroderma (i.e., morphea) typically involves the skin and underlying tissue causing progressive functional and cosmetic disturbances. While the etiology of scleroderma is unknown, it is correlated with autoimmune dysfunction. Linear morphea is a disorder that primarily affects children. This report describes the case of a nine-year-old girl with skin eruptions in the forehead, near the left eye, and in the anterior neck in addition to an underlying focal hemispheric frontal brain atrophy. There is no evidence of neurological deficits in this case. Linear morphea can lead to brain atrophy, causing several neurological dysfunctions such as seizures and cognitive impairment. Follow-up monitoring is critical, and also early recognition of new symptoms for optimal patient outcomes.


  • Open Access

    Arterial Thrombosis in an Asymptomatic COVID-19 Complicated by Malignant Middle Cerebral Artery Syndrome: A Case Report and Literature Review

    by Ali A Alzahrani, Hissah Al Abdulsalam, Hussein Al-Sakkaf, Ayat Yousef, Fahad B Albadr

    Coronavirus disease 2019 (COVID-19) is a severe infectious respiratory disease caused by the novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Multiple studies in the literature highlight the association between COVID-19 and stroke. We report a case of acute ischemic stroke in a COVID-19 patient without displaying symptoms of active COVID-19 infection or risk factors for stroke with further review of the literature. The patient’s recovery was complicated by hemorrhagic stroke, which resulted in death. Acute ischemic strokes are one of the challenging complications of COVID-19 infection. Initial rapid assessment and management are crucial in optimizing the outcomes on these patients. Nevertheless, wearing appropriate PPE should be instituted while providing adequate care.